Evidence map›Paper›PMID 32316981›Full record

ArticleMalaria journal2020

Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon.

Diamantina Moreno-Gutierrez, Angel Rosas-Aguirre, Alejandro Llanos-Cuentas, Joke Bilcke, José Luis Barboza, Marie-Pierre Hayette, Juan Contreras-Mancilla, Kristhian Aguirre, Dionicia Gamboa, Hugo Rodriguez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Diamantina Moreno-GutierrezFacultad de Medicina Humana, Universidad Nacional de la Amazonía Peruana, Iquitos, Loreto, 160, Peru. dlmorenog@gmail.com.
Angel Rosas-AguirreResearch Institute of Health and Society (IRSS), Université Catholique de Louvain, 1200, Brussels, Belgium.
Alejandro Llanos-CuentasInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, 31, Peru.
Joke BilckeCentre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, 2000, Antwerp, Belgium.
José Luis BarbozaInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, 31, Peru.
Marie-Pierre HayetteDepartment of Clinical Microbiology, Center for Interdisciplinary Research on Medicines (CIRM), University Hospital of Liège, 4000, Liège, Belgium.
Juan Contreras-MancillaInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, 31, Peru.
Kristhian AguirreInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, 31, Peru.
Dionicia GamboaInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, 31, Peru.
Hugo RodriguezFacultad de Medicina Humana, Universidad Nacional de la Amazonía Peruana, Iquitos, Loreto, 160, Peru.
Niko SpeybroeckResearch Institute of Health and Society (IRSS), Université Catholique de Louvain, 1200, Brussels, Belgium.
Philippe BeutelsCentre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, 2000, Antwerp, Belgium.
Universidad Peruana Cayetano Heredia · PEUniversidad Nacional de la Amazonía Peruana · PEUniversity of Antwerp · BEFund for Scientific Research · BEUCLouvain · BEUniversity of Liège · BE

Funding

Académie de recherche et d'enseignement supérieur ARES-CCDAcadémie de recherche et d'enseignement supérieur PRD Peru 2014-2019Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica 008-2014-FONDECYT
6 · The paper itself

Abstract

backgroundCase management is one of the principal strategies for malaria control. This study aimed to estimate the economic costs of uncomplicated malaria case management and explore the influence of health-seeking behaviours on those costs.

methodsA knowledge, attitudes and practices (KAP) survey was applied to 680 households of fifteen communities in Mazan-Loreto in March 2017, then a socio-economic survey was conducted in September 2017 among 161 individuals with confirmed uncomplicated malaria in the past 3 months. Total costs per episode were estimated from both provider (Ministry of Health, MoH) and patient perspectives. Direct costs were estimated using a standard costing estimation procedure, while the indirect costs considered the loss of incomes among patients, substitute labourers and companions due to illness in terms of the monthly minimum wage. Sensitivity analysis evaluated the uncertainty of the average cost per episode.

resultsThe KAP survey showed that most individuals (79.3%) that had malaria went to a health facility for a diagnosis and treatment, 2.7% received those services from community health workers, and 8% went to a drugstore or were self-treated at home. The average total cost per episode in the Mazan district was US$ 161. The cost from the provider's perspective was US$ 30.85 per episode while from the patient's perspective the estimated cost was US$ 131 per episode. The average costs per Plasmodium falciparum episode (US$ 180) were higher than those per Plasmodium vivax episode (US$ 156) due to longer time lost from work by patients with P. falciparum infections (22.2 days) than by patients with P. vivax infections (17.0 days). The delayed malaria diagnosis (after 48 h of the onset of symptoms) was associated with the time lost from work due to illness (adjusted mean ratio 1.8; 95% CI 1.3, 2.6). The average cost per malaria episode was most sensitive to the uncertainty around the lost productivity cost due to malaria.

conclusionsDespite the provision of free malaria case management by MoH, there is delay in seeking care and the costs of uncomplicated malaria are mainly borne by the families. These costs are not well perceived by the society and the substantial financial impact of the disease can be frequently undervalued in public policy planning.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultAgedAged, 80 and overCase ManagementChildChild, PreschoolFemaleHumansInfantMalaria, FalciparumMalaria, VivaxMaleMiddle AgedPeruCostEconomicHealth care-seeking behaviourMalariaManagementPeru

Identifiers

PMID32316981
PMCPMC7175533
OpenAlexW3017156762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.